Versapenn (al) Anhydrous Lipid Base Cream
NDC Package 72467-200-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Versapenn (al) Anhydrous Lipid Base cream is a drug for further processing. This formulation utilizes a cream delivery system. Marketed by Specialized Rx Products, L. L. C., this product is identified by NDC 72467-200.

Identification & Billing

NDC Package Code
72467-200-40
Package Description
100 g in 1 CONTAINER
Product Code
72467-200
11-Digit Billing Format
72467020040
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
100 GM

Clinical Specifications

Proprietary Name
Versapenn (al) Anhydrous Lipid Base
Non-Proprietary Name
Versapenn (al) Anhydrous Lipid Base
Substance Name
Titanium Dioxide
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Active Ingredient(s)
TITANIUM DIOXIDE 1 g/g

Regulatory & Marketing

Labeler Name
Specialized Rx Products, L. L. C.
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
07-20-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72467-200-40 identifies a specific commercial package of 100 g in 1 container of Versapenn (al) Anhydrous Lipid Base (UNFINISHED drug), drug for further processing labeled by Specialized Rx Products, L. L. C.. This product is billed per "GM" gram and contains an estimated amount of 100 billable units per package. This cream is formulated for use and contains titanium dioxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Specialized Rx Products, L. L. C. on July 20, 2022. The current certification is valid through December 31, 2026.

How is this Specialized Rx Products, L. L. C. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72467020040. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72467-200-40
11-Digit CMS (5-4-2)
72467-0200-40

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.